Chihiro Yamamoto
6PUBLICATIONS
20CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 07, 2026
Cost-effectiveness of blinatumomab as post-remission therapy in adults with measurable residual disease-negative, Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia.Chihiro Yamamoto, Teruaki Yamaguchi, Seina Honda
|Jun 26, 2023
Antibody-mediated pathogenesis of chronic GVHD through DBY/HLA class II complexes and induction of a GVL effect.Kento Umino, Kaoru Morita, Takashi Ikeda
|Jan 20, 2023
Relapsed and refractory multiple myeloma: A systematic review and network meta-analysis of the efficacy of novel therapies.Daisuke Minakata, Shin-Ichiro Fujiwara, Daizo Yokoyama
|May 17, 2022
Daratumumab in first-line therapy is cost-effective in transplant-eligible patients with newly diagnosed myeloma.Chihiro Yamamoto, Daisuke Minakata, Shunsuke Koyama
|Nov 03, 2020
Identification of endoscopic factors that predict poor responses to steroids in patients with gastrointestinal acute graft-versus-host disease.Kaoru Morita, Shin-Ichiro Fujiwara, Takashi Ikeda
Pageof 1
Frequent Collaborators
5 joint publications
Kazuya Sato
3 joint publications
Kaoru Morita
3 joint publications
Yoshinobu Kanda
3 joint publications
Shin-Ichiro Fujiwara
2 joint publications
Kiyomi Mashima
2 joint publications
Takashi Nagayama
2 joint publications
Daisuke Minakata
1 joint publications
Hirotomo Nakashima
1 joint publications
Shun-Ichi Kimura
1 joint publications
Noriko Doki
